In 2023, the global healthcare regulatory affairs outsourcing market was estimated to be valued at USD 2,203.40 million. During the forecast period, the market is likely to garner a moderate CAGR of 6.70%. By 2034, the market is predicted to gain a valuation of USD 4,052.30 million by 2034.
| Report Attribute | Details |
|---|---|
| Estimated Market Value in 2023 | USD 2,203.40 million |
| Expected Market Value in 2024 | USD 2,118.60 million |
| Projected Forecast Value in 2034 | USD 4,052.30 million |
| Anticipated Growth Rate from 2024 to 2034 | 6.70% |
Market players are offering healthcare firms with functional outsourcing to enhance efficiency. These outsourcing companies offer the healthcare forms to contract multiple monitors (CRAs), coordinators, senior monitors, and project managers for a particular period of time. This would help them to support the internal resources without the expansion of their own clinical team.
The outsourcing services have dedicated clinical experts working under the project management of the clients. They mostly offer FTE based budgets, with predictable and fixed pricing.
Healthcare companies will have a single point of contact with these outsourcing firms. All the staffing requirements, from changing needs to operational and financial management of the projects, will be taken care of.
The global demand for the healthcare regulatory affairs outsourcing market was estimated to reach a valuation of USD 1,123.80 million in 2018, according to a report from Future Market Insights. From 2018 to 2023, the healthcare regulatory affairs outsourcing market witnessed significant growth, registering a CAGR of 12.10%.
| Historical CAGR from 2018 to 2023 | 12.10% |
|---|---|
| Forecast CAGR from 2024 to 2034 | 6.70% |
The growth of biotechnology and pharmaceutical companies is a major factor driving the healthcare regulatory affairs outsourcing market as they require effective regulatory plans and submissions.
Companies are spending more and more on outsourcing partners for specific regulatory knowledge as they struggle to bring new goods to market. This helps them navigate complex regulatory frameworks, gain a competitive edge, and ensure compliance and timely market entrance
Cost Savings, Increased Efficiency and Regulatory Compliance to Push Companies toward these Services
Companies can avoid the overhead expenses associated with having an in-house regulatory affairs staff. With outsourcing, companies may pay for just the work completed, giving them flexibility.
Efficiency gains are possible through outsourcing. There are various kinds of core and non-core activities within a healthcare company. By outsourcing the non-core activities, companies can devote more time towards the core activities and enhance the efficiency.
With the evolving regulatory framework of various bodies, the healthcare companies find it quite difficult to abide by it all at the same time. They prefer to outsource such responsibilities to a third company that holds better knowledge of all these.
High Initials Costs and Technological Challenges to Restrict Market Growth
Healthcare regulatory affairs outsourcing services have a lot of advantages for the healthcare companies. But there are some serious complications with data too. By outsourcing services, healthcare companies will face a loss of control over their own critical processes.
Companies have to provide the outsourcing forms with their complete set of data, which can lead to patient data leak and vulnerabilities. A lack of direct monitoring and control over outsourced medical billing and collections could make patient data vulnerable. Factors such as these can hinder the global market growth eventually.
This section focuses on providing detailed analysis of two particular market segments for the healthcare regulatory affairs outsourcing, the dominant service type and the significant end user. The two main segments discussed below are the regulatory writing and publishing service and mid-size pharmaceutical companies.
| Services | Regulatory Writing and Publishing |
|---|---|
| Market Share in 2023 | 33.60% |
In 2023, the regulatory writing and publishing service was estimated to gain a market share of 33.60%. This is because there is a growing need for thorough documentation and submission assistance.
Companies are looking for qualified experts to guarantee correct and timely submissions due to changing legislation and tighter compliance standards. Companies in the healthcare sector can improve productivity, simplify procedures, and successfully comply with regulations by outsourcing these jobs.
| End User | Mid-Sized Pharmaceutical Companies |
|---|---|
| Market Share in 2023 | 29.20% |
In 2023, the mid-size pharmaceutical companies were estimated to be the dominant end user for the healthcare regulatory affairs outsourcing market. They may accelerate product development schedules, handle complicated compliance needs with efficiency, and concentrate resources on key capabilities by outsourcing regulatory affairs.
The ability to obtain expertise catered to their particular requirements is one notable benefit of outsourcing regulatory affairs for mid-sized pharmaceutical companies. This enables them to successfully negotiate complicated regulatory landscapes while concentrating on the core operations. They may now more successfully compete in the market while still adhering to legal requirements due to this.
This section will go into detail on the healthcare regulatory affairs outsourcing markets in a few key countries, including the United States, the United Kingdom, Spain, Thailand and Indonesia. This part will focus on the key factors that are driving up demand in these countries for the healthcare regulatory affairs outsourcing.
| Countries | CAGR from 2024 to 2034 |
|---|---|
| The United States | 3.40% |
| The United Kingdom | 3.80% |
| Spain | 4.40% |
| Thailand | 5.30% |
| Indonesia | 4.50% |
The United States healthcare regulatory affairs outsourcing ecosystem is anticipated to gain a CAGR of 3.40% through 2034. Continuous innovation in healthcare technology necessitates faster regulatory processes in order to bring novel products to market as quickly as possible.
Outsourcing regulatory affairs enables businesses to use professional expertise and resources to speed approvals, assuring rapid market access while conforming to regulatory requirements.
The healthcare regulatory affairs outsourcing market in the United Kingdom is expected to expand with a 3.80% CAGR through 2034. Brexit, the United Kingdom's exit from the European Union, still causes regulations in the healthcare industry to be out of compliance with EU standards.
Companies who operate in both the United Kingdom's and the European Union's markets face difficulties as a result of this possible regulatory divergence since they have to deal with several regulatory regimes.
After Brexit, specialized knowledge becomes necessary to comprehend and abide by the changing British rules. Companies may conveniently acquire this knowledge by outsourcing regulatory affairs, which guarantees that they can maintain compliance and adjust to new needs while concentrating on their core business operations.
The healthcare regulatory affairs outsourcing ecosystem in Spain is anticipated to develop with a 4.40% CAGR from 2024 to 2034.Spain's distinct cultural and linguistic characteristics necessitate specialized expertise for most effective regulatory compliance.Regulatory affairs might be outsourced to companies with local knowledge to enable more efficient understanding and communication of regulations.
The healthcare regulatory affairs outsourcing industry in Thailand is anticipated to reach a 5.30% CAGR from 2024 to 2034. The healthcare industry in Thailand is at present aimed at aligned its regulations with that of the international norms and standards.
This step requires immense expertise and knowledge, pushing them towards outsourcing agencies. Regulatory affairs outsourcing provides access to expert knowledge necessary for effectively navigating these dynamic regulatory regimes.
The healthcare regulatory affairs outsourcing ecosystem in Indonesia is likely to evolve with a 4.50% CAGR during the forecast period.
Indonesia has got certain strict regulatory bodies for various medical devices and pharmaceutical drugs. These regulations are stated by bodies like the National Agency of Drug and Food Control (NADFC) functioning under the Indonesian Ministry of Health (MoH).
In order to comply with the changing regulations from these bodies, companies require investments to overcome the hurdles. Market players in Indonesia, thus, take help from various healthcare companies to get large scale investments to meet regulatory compliance.
Market players are actively offering specialized regulatory assistance to biotechnology, pharmaceutical, and medical device companies within the healthcare regulatory affairs outsourcing market.
They provide proficiency in navigating through intricate regulatory structures, guaranteeing adherence to legal statutes and guidelines, and hastening the approvals for the research and studies.
Companies also provide a variety of services, such as pharmacovigilance, submission preparation, regulatory strategy development, and compliance monitoring. They want to reduce the regulatory restrictions consumers face in order to promote healthcare facilities more efficiently and in conformity with quality standards.
This suggests that the market players are simply aimed at easing down the various restrictions that organizations face due to legal restrictions. The key players in this market include:
Key Development by Market Players
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 6.70% from 2024 to 2034 |
| Market value in 2024 | USD 2,118.60 million |
| Market value in 2034 | USD 4,052.30 million |
| Base Year for Estimation | 2023 |
| Historical Data | 2018 to 2023 |
| Forecast Period | 2024 to 2034 |
| Quantitative Units | USD million for value |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | Services, End User, Region |
| Regions Covered | North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; The Middle East & Africa |
| Countries Profiled |
The United States, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Spain, Italy, Poland, Russia, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC Countries, South Africa, Israel |
| Key Companies Profiled | Accell Clinical Research LLC; Charles River Laboratories; Syneos Health; Laboratory Corporation of America Holdings; ICON PLC.; IQVIA; Medpace, Inc.; PAREXEL International Corporation; Thermo Fisher Scientific Inc. (PPD); Promedica International; WuXi App Tec |
| Customisation Scope | Available on Request |
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 2: Global Market Value (US$ Million) Forecast by Services, 2019 to 2034
Table 3: Global Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 4: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 5: North America Market Value (US$ Million) Forecast by Services, 2019 to 2034
Table 6: North America Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 8: Latin America Market Value (US$ Million) Forecast by Services, 2019 to 2034
Table 9: Latin America Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 10: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 11: Western Europe Market Value (US$ Million) Forecast by Services, 2019 to 2034
Table 12: Western Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 13: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 14: Eastern Europe Market Value (US$ Million) Forecast by Services, 2019 to 2034
Table 15: Eastern Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 16: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 17: South Asia and Pacific Market Value (US$ Million) Forecast by Services, 2019 to 2034
Table 18: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 19: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 20: East Asia Market Value (US$ Million) Forecast by Services, 2019 to 2034
Table 21: East Asia Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Services, 2019 to 2034
Table 24: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2019 to 2034
Figure 1: Global Market Value (US$ Million) by Services, 2024 to 2034
Figure 2: Global Market Value (US$ Million) by End User, 2024 to 2034
Figure 3: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 7: Global Market Value (US$ Million) Analysis by Services, 2019 to 2034
Figure 8: Global Market Value Share (%) and BPS Analysis by Services, 2024 to 2034
Figure 9: Global Market Y-o-Y Growth (%) Projections by Services, 2024 to 2034
Figure 10: Global Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 11: Global Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 12: Global Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 13: Global Market Attractiveness by Services, 2024 to 2034
Figure 14: Global Market Attractiveness by End User, 2024 to 2034
Figure 15: Global Market Attractiveness by Region, 2024 to 2034
Figure 16: North America Market Value (US$ Million) by Services, 2024 to 2034
Figure 17: North America Market Value (US$ Million) by End User, 2024 to 2034
Figure 18: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 19: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 22: North America Market Value (US$ Million) Analysis by Services, 2019 to 2034
Figure 23: North America Market Value Share (%) and BPS Analysis by Services, 2024 to 2034
Figure 24: North America Market Y-o-Y Growth (%) Projections by Services, 2024 to 2034
Figure 25: North America Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 26: North America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 27: North America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 28: North America Market Attractiveness by Services, 2024 to 2034
Figure 29: North America Market Attractiveness by End User, 2024 to 2034
Figure 30: North America Market Attractiveness by Country, 2024 to 2034
Figure 31: Latin America Market Value (US$ Million) by Services, 2024 to 2034
Figure 32: Latin America Market Value (US$ Million) by End User, 2024 to 2034
Figure 33: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 37: Latin America Market Value (US$ Million) Analysis by Services, 2019 to 2034
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Services, 2024 to 2034
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Services, 2024 to 2034
Figure 40: Latin America Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 41: Latin America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 43: Latin America Market Attractiveness by Services, 2024 to 2034
Figure 44: Latin America Market Attractiveness by End User, 2024 to 2034
Figure 45: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 46: Western Europe Market Value (US$ Million) by Services, 2024 to 2034
Figure 47: Western Europe Market Value (US$ Million) by End User, 2024 to 2034
Figure 48: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 49: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 50: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 51: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 52: Western Europe Market Value (US$ Million) Analysis by Services, 2019 to 2034
Figure 53: Western Europe Market Value Share (%) and BPS Analysis by Services, 2024 to 2034
Figure 54: Western Europe Market Y-o-Y Growth (%) Projections by Services, 2024 to 2034
Figure 55: Western Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 56: Western Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 57: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 58: Western Europe Market Attractiveness by Services, 2024 to 2034
Figure 59: Western Europe Market Attractiveness by End User, 2024 to 2034
Figure 60: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 61: Eastern Europe Market Value (US$ Million) by Services, 2024 to 2034
Figure 62: Eastern Europe Market Value (US$ Million) by End User, 2024 to 2034
Figure 63: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 64: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 65: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 66: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 67: Eastern Europe Market Value (US$ Million) Analysis by Services, 2019 to 2034
Figure 68: Eastern Europe Market Value Share (%) and BPS Analysis by Services, 2024 to 2034
Figure 69: Eastern Europe Market Y-o-Y Growth (%) Projections by Services, 2024 to 2034
Figure 70: Eastern Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 71: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 72: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 73: Eastern Europe Market Attractiveness by Services, 2024 to 2034
Figure 74: Eastern Europe Market Attractiveness by End User, 2024 to 2034
Figure 75: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 76: South Asia and Pacific Market Value (US$ Million) by Services, 2024 to 2034
Figure 77: South Asia and Pacific Market Value (US$ Million) by End User, 2024 to 2034
Figure 78: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 79: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 80: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 81: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 82: South Asia and Pacific Market Value (US$ Million) Analysis by Services, 2019 to 2034
Figure 83: South Asia and Pacific Market Value Share (%) and BPS Analysis by Services, 2024 to 2034
Figure 84: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Services, 2024 to 2034
Figure 85: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 86: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 87: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 88: South Asia and Pacific Market Attractiveness by Services, 2024 to 2034
Figure 89: South Asia and Pacific Market Attractiveness by End User, 2024 to 2034
Figure 90: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 91: East Asia Market Value (US$ Million) by Services, 2024 to 2034
Figure 92: East Asia Market Value (US$ Million) by End User, 2024 to 2034
Figure 93: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 94: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 95: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 96: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 97: East Asia Market Value (US$ Million) Analysis by Services, 2019 to 2034
Figure 98: East Asia Market Value Share (%) and BPS Analysis by Services, 2024 to 2034
Figure 99: East Asia Market Y-o-Y Growth (%) Projections by Services, 2024 to 2034
Figure 100: East Asia Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 101: East Asia Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 102: East Asia Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 103: East Asia Market Attractiveness by Services, 2024 to 2034
Figure 104: East Asia Market Attractiveness by End User, 2024 to 2034
Figure 105: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 106: Middle East and Africa Market Value (US$ Million) by Services, 2024 to 2034
Figure 107: Middle East and Africa Market Value (US$ Million) by End User, 2024 to 2034
Figure 108: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 109: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 110: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 111: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 112: Middle East and Africa Market Value (US$ Million) Analysis by Services, 2019 to 2034
Figure 113: Middle East and Africa Market Value Share (%) and BPS Analysis by Services, 2024 to 2034
Figure 114: Middle East and Africa Market Y-o-Y Growth (%) Projections by Services, 2024 to 2034
Figure 115: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 116: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 117: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 118: Middle East and Africa Market Attractiveness by Services, 2024 to 2034
Figure 119: Middle East and Africa Market Attractiveness by End User, 2024 to 2034
Figure 120: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
The healthcare regulatory affairs outsourcing market is expected to garner a 6.70% CAGR from 2024 to 2034.
By 2024, the global healthcare regulatory affairs outsourcing market is likely to gain USD 2,118.60 million.
By 2034, the healthcare regulatory affairs outsourcing market valuation is likely to reach a sum of USD 4,052.30 million.
The healthcare regulatory affairs outsourcing industry in the United States is likely to rise at a 3.40% CAGR during the forecast period.
The regulatory writing and publishing segment is likely to gain traction in the global healthcare regulatory affairs outsourcing market with a 33.60% market share in 2023.
The mid-size pharmaceutical companies are likely to be the dominant end user of healthcare regulatory affairs outsourcing, with a 29.20% market share in 2023.
Explore Similar Insights
Healthcare Regulatory Affairs Outsourcing Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
